Girirajan Santhosh, Vlangos Christopher N, Szomju Barbara B, Edelman Emily, Trevors Christopher D, Dupuis Lucie, Nezarati Marjan, Bunyan David J, Elsea Sarah H
Department of Human Genetics, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, Virginia 23298, USA.
Genet Med. 2006 Jul;8(7):417-27. doi: 10.1097/01.gim.0000228215.32110.89.
Smith-Magenis syndrome (SMS) is a complex disorder that includes mental retardation, craniofacial and skeletal anomalies, and behavioral abnormalities. We report the molecular and genotype-phenotype analyses of 31 patients with SMS who carry 17p11.2 deletions or mutations in the RAI1 gene.
Patients with SMS were evaluated by fluorescence in situ hybridization and/or sequencing of RAI1 to identify 17p11.2 deletions or intragenic mutations, respectively, and were compared for 30 characteristic features of this disorder by the Fisher exact test.
In our cohort, 8 of 31 individuals carried a common 3.5 Mb deletion, whereas 10 of 31 individuals carried smaller deletions, two individuals carried larger deletions, and one individual carried an atypical 17p11.2 deletion. Ten patients with nondeletion harbored a heterozygous mutation in RAI1. Phenotypic comparison between patients with deletions and patients with RAI1 mutations show that 21 of 30 SMS features are the result of haploinsufficiency of RAI1, whereas cardiac anomalies, speech and motor delay, hypotonia, short stature, and hearing loss are associated with 17p11.2 deletions rather than RAI1 mutations (P<.05). Further, patients with smaller deletions show features similar to those with RAI1 mutations.
Although RAI1 is the primary gene responsible for most features of SMS, other genes within 17p11.2 contribute to the variable features and overall severity of the syndrome.
史密斯-马吉尼斯综合征(SMS)是一种复杂的疾病,包括智力发育迟缓、颅面和骨骼异常以及行为异常。我们报告了31例携带17p11.2缺失或RAI1基因突变的SMS患者的分子及基因型-表型分析。
通过荧光原位杂交和/或RAI1测序对SMS患者进行评估,分别鉴定17p11.2缺失或基因内突变,并通过Fisher精确检验比较该疾病的30个特征。
在我们的队列中,31例个体中有8例携带常见的3.5 Mb缺失,而31例个体中有10例携带较小的缺失,2例个体携带较大的缺失,1例个体携带非典型的17p11.2缺失。10例非缺失患者在RAI1中存在杂合突变。缺失患者与RAI1突变患者的表型比较表明,30个SMS特征中的21个是RAI1单倍剂量不足的结果,而心脏异常、言语和运动发育迟缓、肌张力低下、身材矮小和听力损失与17p11.2缺失而非RAI1突变相关(P<0.05)。此外,较小缺失的患者表现出与RAI1突变患者相似的特征。
虽然RAI1是导致SMS大多数特征的主要基因,但17p11.2内的其他基因也导致了该综合征的可变特征和总体严重程度。